CYTOSYSTEMS

Cytosystems is a pathology company that develops non-invasive cancer diagnostic and stratification technologies for initially for the management of bladder cancer. The company’s first product, BladderLight™, is an integrated and automated digital pathology solution using a big data systems approach for the diagnosis and monitoring of bladder cancer. Cytosystems has developed two patent-pending technologies: a point of care cell collection device which optimizes analyte quality at point o... f patient care and the use of artificial intelligence pattern recognition software to interrogate and objectively classify individual urothelial cells as cancer positive or negative. This whole-cell approach can help with clinical decision making and provides a highly sensitive and specific test which achieves the challenging performance levels demanded of a non-invasive test by patients and clinicians.More